UpcomingPDUFA target action date

Zeleciment rostudirsen (DYNE-251)

Dyne Therapeutics (DYN)

Marketer take

Another DMD decision close to Deramiocel's, so DMD brand and advocacy teams face a busy, crowded news cycle.

Sponsor company
Dyne Therapeutics (DYN)
Indication
Duchenne muscular dystrophy (DMD)
Therapeutic area
Neurology, Rare disease
Event
PDUFA target action date
Date
Jan 21, 2027
Status
Upcoming
Source
company press release
Last verified
Nov 15, 2026

Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?

Get alerts when FDA dates move